Summary
This prediction is currently active. With a performance of -9.23%, the BUY prediction for Altimmune by Truist_Financial_Co_ is down slightly. This prediction currently runs until 18.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | -1.808% | -1.808% |
| iShares Core DAX® | -0.218% | 1.751% |
| iShares Nasdaq 100 | -2.352% | 0.218% |
| iShares Nikkei 225® | -3.105% | 2.933% |
| iShares S&P 500 | -0.497% | 1.985% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Altimmune diskutieren
Altimmune (ALT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for ALT provided by MarketBeat